In addition to the Phase 3 program, mipomersen is being tested in statin-intolerant patients in a Phase 2 study and alternative dosing regimens of mipomersen are being tested in Phase 1 studies.
In addition to the Phase 3 program, mipomersen has been tested in statin-intolerant patients in a small Phase 2 study. Also, alternative dosing regimens of mipomersen are being tested in Phase 1 studies.